A comprehensive view of Kit Check Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.
Bluesight's ControlCheck drug diversion monitoring system is 6.6 times more likely to detect diversion than other systems, company says; ControlCheck identified 808 cases of drug diversion in 2023, showing efficacy in safeguarding healthcare institutions
Published:
February 07, 2024
by Kit Check Inc.
|
Bluesight appoints Jason Vander Meer as chief product officer to expand its Medication Intelligence solutions, develop new products that improve efficiency, reduce medication costs, increase compliance, safety
Published:
October 26, 2023
by Kit Check Inc.
|
Thoma Bravo announces strategic growth investment in Bluesight to enhance its drug diversion prevention offerings through its acquisition of Medacist; Bluesight supports health systems with automated RFID-enabled kit and tray management through KitCheck
Published:
July 17, 2023
by Kit Check Inc.
|
United States Patent for Identifying Discrepancies Between Events from Disparate Systems Issued to Kit Check Inc and Bluesight Inc
Published:
June 03, 2023
by Information Technology Patent News
|
Fresenius Kabi, a provider of injectable medications, launches Rocuronium Bromide Injection with advanced RFID-enabled labels, its first product compatible with Bluesight’s KitCheck System, a kit and tray solution for hospitals allowing use of RFID
Published:
May 24, 2023
by Kit Check Inc.
|
Ask us about our Logistic & Supply Chain market view